Linda R. Peterson, MD, FACC, FAHA, FASE

Professor of Medicine and Radiology


  • BS Biology: Georgetown University, Washington, DC (1986)
  • MD: Washington University School of Medicine, St. Louis, MO (1990)
  • Internship, Medicine: Washington University, Barnes Hospital, St. Louis, MO (1991)
  • Residency, Medicine: Washington University, Barnes Hospital, St. Louis, MO (1993-1995)
  • Fellowship, Cardiology: Washington University, Barnes Hospital, St. Louis, MO (1996-2000)

Board Certifications

  • Cardiovascular Diseases
  • Echocardiology


  • Academic Women’s Network “Mentoring Award,” Washington U. School of Medicine, 2014
  • Washington U. Medical Center Alumni Association “Distinguished Alumni Scholarship Honoree”, 2013
  • Alpha Omega Alpha Medical Honor Society, 2012
  • Winner, First American Society of Nuclear Medicine/Amerscham Award, 1997
  • Knowlton ‘Incentive for Excellence’ Award, Internal Medicine Program, Washington University School of Medicine, 1994
  • Washington University Resident Teaching Award, 1993
  • Winner, Syntex/Medicine award for excellence in clinical practice, 1993
  • Magna Cum Laude, Georgetown University, 1986
  • Francis Graham Medal of Academic and Athletic Achievement, Georgetown University, 1986

Clinical Interests

I am the Medical Director of Cardiac Rehabilitation at Barnes-Jewish Hospital, where we have  started the first-ever outpatient Intensive Cardiac Rehabilitation Program using the Pritikin program. 2D-echocardiography. tissue Doppler and strain rate analysis. I am also interested in peak oxygen consumption testing and its application to prediction of prognosis in patients with heart failure.

Research Interests

Because obesity is a national epidemic and contributes to between 11 and 14% of all cases of heart failure, I am dedicated to investigating the causes of obesity-related cardiac dysfunction. In particular, I am interested in what role alterations in myocardial metabolism play in the development of cardiac dysfunction and/or the adaptation of the heart to new conditions. My work is translational and conducted in humans subjects. I use multiple different imaging and metabolic techniques to quantify the myocardial alterations seen in obesity and heart failure. Chief among these are positron emission tomography, echocardiography, magnetic resonance imaging, magnetic resonance spectroscopy, and whole body substrate kinetics. I also study metabolic manipulation’s effects in cancer treatment  as well as the relationship between specific lipid species, ceramides, and LV function and outcomes. My most recent research has focused on the role of dietary nitrates in exercise performance in patients with heart failure.


View publications on